Palmeira, A.; Sousa, E.; Köseler, A.; Sabirli, R.; Gören, T.; Türkçüer, İ.; Kurt, Ö.; Pinto, M.M.; Vasconcelos, M.H.
Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132. Pharmaceuticals 2024, 17, 411.
https://doi.org/10.3390/ph17040411
AMA Style
Palmeira A, Sousa E, Köseler A, Sabirli R, Gören T, Türkçüer İ, Kurt Ö, Pinto MM, Vasconcelos MH.
Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132. Pharmaceuticals. 2024; 17(4):411.
https://doi.org/10.3390/ph17040411
Chicago/Turabian Style
Palmeira, Andreia, Emília Sousa, Aylin Köseler, Ramazan Sabirli, Tarık Gören, İbrahim Türkçüer, Özgür Kurt, Madalena M. Pinto, and M. Helena Vasconcelos.
2024. "Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132" Pharmaceuticals 17, no. 4: 411.
https://doi.org/10.3390/ph17040411
APA Style
Palmeira, A., Sousa, E., Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., Kurt, Ö., Pinto, M. M., & Vasconcelos, M. H.
(2024). Correction: Palmeira et al. Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection. Pharmaceuticals 2020, 13, 132. Pharmaceuticals, 17(4), 411.
https://doi.org/10.3390/ph17040411
